Agenus Stock Soars 83%, but $255 Million of Its $340 Million Lifeline Is Still Conditional
NEW YORK, July 14, 2026, 04:31 (EDT) Agenus Inc. (NASDAQ:AGEN) shares closed 82.7% higher at $6.12 on Monday after the cancer-drug developer unveiled financing of up to $340 million for a pivotal…
Read the full articleYou might also wanna read
Agenus (AGEN) Stock Jumps 13% After Securing $340M Financing Package
Agenus (AGEN) stock surged 13% premarket after securing $85M in financing with potential for $340M total to fund cancer trials through 2031.
Agenus Secures $85M in Private Placement Financing (AGEN)
Related Stocks: AGEN
Alnylam Pharmaceuticals (NASDAQ:ALNY) Shows Accelerating Momentum as a High Growth Stock
Louis Navellier's strategy identifies high-potential stocks with eight fundamental rules, and Alnylam Pharmaceuticals (ALNY) perfectly fits
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today
SpaceX stock passes Amazon in market cap after record IPO
SpaceX stock has risen around 50% since its Nasdaq debut last Friday, pushing its valuation above $2.66 trillion at Tuesday's close
qz.com·12d ago
Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today?
Investors favored companies benefiting from biotech deals, rising power demand from AI data centers, and cost-cutting efforts to improve pro
Comments
Sign in to join the conversation.
No comments yet. Be the first.